FDA Warning on Xylazine: Mitigating Human Risk | by: Sumeet Singh, Founder & Chairman | Article Posted: November 6, 2023 | The U.S. Food and Drug Administration (FDA) has issued a warning regarding mitigating risks from human Xylazine exposure. FDA has not...
New FDA Clarification Allows Wholesale by 503B Facilities to 503A Pharmacies | by: Sumeet Singh, Founder & Chairman | Article Posted: July 5,...
Navigating the Prescription Drug Reform Act: A New Landscape for Drug Manufacturers in Florida | by: Kelly DiBattista, Esq., Research Director |...
| Short-Dated Drug Return Scheme Becomes Short-Dated | by: Sumeet Singh, Founder & Chairman | Article Posted: July 5, 2023 | Returns in the Drug...
Alabama’s New Rule Has Massive DSCSA Implications on State Regulations | by: Sumeet Singh, Founder & Chairman | Article Posted: May 24, 2023 |...
New FDA - OA REMS Announcement | by: Deneen Fumich, RPh | Article Posted: May 2, 2023 | April 21, 2022, FDA published in the Federal Register open...
| New Oklahoma Rules for Shipping Mail-Order Medications | by: Deneen Fumich, RPh | Article Posted: April 5, 2023 | Pharma Solutions reported on...
